Search research articles
Contact Us
Filters
Showing results (121-130 of 168) with videos related to
Page
of 17
Sort By:
Clinical Genitourinary Cancer
|
April 18, 2020
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer
David C Smith, Stephanie Daignault-Newton, Petros Grivas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial
Maha H A Hussain, Gary R MacVicar, Daniel P Petrylak, et al.
Investigational New Drugs
|
August 23, 2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma
Tycel Phillips, Paul M Barr, Steven I Park, et al.
British Journal of Cancer
|
May 4, 2021
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
Jordi Rodon, Guillem Argilés, Roisin M Connolly, et al.
Nano Letters
|
January 23, 2018
Exploration of the Smallest Diameter Tin Nanowires Achievable with Electrodeposition: Sub 7 nm Sn Nanowires Produced by Electrodeposition from a Supercritical Fluid
Philip N Bartlett, Richard Beanland, Jennifer Burt, et al.
The Oncologist
|
January 24, 2013
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer
Emmanuel S Antonarakis, Elisabeth I Heath, David C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C Mitchell, Omid Hamid, David C Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Electrodeposition of metals from supercritical fluids
Jie Ke, Wenta Su, Steven M Howdle, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
October 14, 2015
Modelling marine protected areas: insights and hurdles
Elizabeth A Fulton, Nicholas J Bax, Rodrigo H Bustamante, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 168) with videos related to
Sort By:
Page
of 17
Clinical Genitourinary Cancer
|
April 18, 2020
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer
David C Smith, Stephanie Daignault-Newton, Petros Grivas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial
Maha H A Hussain, Gary R MacVicar, Daniel P Petrylak, et al.
Investigational New Drugs
|
August 23, 2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma
Tycel Phillips, Paul M Barr, Steven I Park, et al.
British Journal of Cancer
|
May 4, 2021
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
Jordi Rodon, Guillem Argilés, Roisin M Connolly, et al.
Nano Letters
|
January 23, 2018
Exploration of the Smallest Diameter Tin Nanowires Achievable with Electrodeposition: Sub 7 nm Sn Nanowires Produced by Electrodeposition from a Supercritical Fluid
Philip N Bartlett, Richard Beanland, Jennifer Burt, et al.
The Oncologist
|
January 24, 2013
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer
Emmanuel S Antonarakis, Elisabeth I Heath, David C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C Mitchell, Omid Hamid, David C Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Electrodeposition of metals from supercritical fluids
Jie Ke, Wenta Su, Steven M Howdle, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
October 14, 2015
Modelling marine protected areas: insights and hurdles
Elizabeth A Fulton, Nicholas J Bax, Rodrigo H Bustamante, et al.
Page
of 17